Retinopathy of Prematurity
Conditions
Interventions
It is an interventional, single arm, nonrandomized, nonblinded study in which a total of 103 patients born less than 33 weeks of gestational age and/or with a birth weight of less than 1500 grams rece
D10.212.302.380.410.210
Sponsors
Secretaria Estadual da Saúde de Santa Catarina
Maternidade Darcy Vargas
Hospital Regional Hans Dieter Schmidt
Eligibility
Age
No minimum to 33 Weeks
Inclusion criteria
Inclusion criteria: Premature babies with mothers older than 18 years of age; up to 33 gestational age; who were born at Maternidade Darcy Vargas from March 1 2020 to August 31 2022 whose mothers have signed the Free and Informed Consent Form
Exclusion criteria
Exclusion criteria: Premature babies with congenital eye malformation; whose mothers have been supplemented with omega-3 and who have had infectious diseases
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluate the effect of oral oil drops of docosahexaenoic acid supplementation in the retinopathy of prematurity establishment, expect to find a reduction of 30% in the incidence of the ocular disease detected by indirect binocular ophthalmoscopy examnation after the use of docosahexaenoic acid | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluate the effect of oral oil drops of docosahexaenoic acid supplementation in the sleep pattern of the babies using the Brief Infant Sleep Questionnaire (BISQ). Expect to find better outcomes of sleep in those babies whose used the docosahexaenoic acid | — |
Countries
Brazil
Contacts
Public ContactLuciano Lorenzi
Universidade da Região de Joinville
Outcome results
None listed